The official blog of the Lung Institute.

Lung Disease Treatment Brings Joy This Holiday Season

3 Dec 2013
| Under Press | Posted by
Lung Disease Treatment Brings Joy this Holiday Season

Lung Institute’s Cellular Therapies Are Helping Patients Travel to Visit Loved Ones

Tampa, Fla. (December 3, 2013) – For many patients with lung disease, traveling is something that they must be carefully considered. Due to the oxygen-deficient environment of an airborne plane, sufferers often have more difficulty breathing than usual. This can be frightening when the person feels as if he or she cannot breathe. As a result, many with lung disease choose to stay home for the holidays, or have family come to them instead.

This was the case for a pulmonary fibrosis sufferer from Tallahassee, Florida. He not only wanted to breathe better, but he also wanted to be able to visit his children in Tallahassee and Alabama more easily, as well as play with his grandchildren. To him and many sufferers of lung disease, spending quality time with family, especially over the holidays, is important.

Lung diseases like chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis and pulmonary fibrosis are a major cause of death around the world. COPD alone is categorized as the third leading cause of mortality in the United States and top five leading cause of death worldwide. The physical symptoms of lung disease, such as fatigue and shortness of breath can be hurdles for those afflicted. However, it is the impact on the person’s quality of life that takes a heavy toll on overall well-being.

While visiting the Lung Institute in Tampa, FL, he received two rounds of cellular therapys derived from his own body.  At his follow-up interview, he reported that he is feeling considerably better. Upon being asked if traveling is going to be easier for him this season, he responded that he’s feeling much better and can travel more easily.

About the Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.